Reframe your views on Alzheimer’s disease
Scientists at the University of Antioquia in Medelln and San Francisco’s California University have found that a family member with mild cognitive impairment (MCI) may be protected against Alzheimer’s disease via a combination of model systems. Genetic testing revealed that PSEN1 was not her only mutation gene. The APOE4 gene is a major risk factor for late-onset Alzheimer’s disease.
Perspective changes on Alzheimer’s disease
Amyloid-Plasma, Taus and Neurologic inflammation are believed to be the main factors in Alzheimer’s disease, according to a new study. The study, published in Nature Communications, revealed that the inflammatory response by the immune system suppresses neuronal function and accelerates the formation of amyloid- plaques and tau. It found that the inflammation is linked to early plaque formation.
Alzheimer’s treatment can be used in the future
Scientists have found that brain tissue of people with Alzheimer’s disease, which had bulging lysosomes spilling waste into the brain, was made to contain shorter amounts of amyloid- plaques. Researchers said this might help reduce the risk of getting Alzheimer’s by changing the balance between short and longer strings of amyloid- plaques. Alzheimer’s is a neurodegenerative disease that causes memory loss.